Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Soliris (eculizumab)

Indications: Neuromyelitis optica spectrum disorder

Call For Patient Input: January 24, 2020

Patient Input Closed: March 16, 2020

Vonvendi (von Willebrand Factor [recombinant])

Indications: von Willebrand disease, adults (perioperative management)

Call For Patient Input: January 2, 2020

Patient Input Closed: February 21, 2020

Vonvendi (von Willebrand Factor [recombinant])

Indications: von Willebrand disease, adults (treatment)

Call For Patient Input: January 2, 2020

Patient Input Closed: February 21, 2020

Duobrii (Halobetasol propionate and tazarotene)

Indications: Psoriasis, moderate to severe plaque

Call For Patient Input: December 19, 2019

Patient Input Closed: February 14, 2020